Drug & intervention

vortioxetine

RxCUI 1455099

Clinical trials46
Recruiting1
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

40 shown
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)NCT07266545 · 2026-02-17
RECRUITING
Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in KoreaNCT04446039 · 2022-07-04
COMPLETED
Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive AbilitiesNCT05104918 · 2022-02-01
UNKNOWN
Cognitive Effects of Adjuvant Vortioxetine in Early SchizophreniaNCT04895488 · 2022-01-20
UNKNOWN
Vortioxetine to Prevent Return of Symptoms in Children With DepressionNCT05014919 · 2021-08-10
TERMINATED
Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective DisordersNCT05840861 · 2020-11-05
UNKNOWN
Effect of Vortioxetine on Cognitive Symptoms in Patients With SchizophreniaNCT04456777 · 2020-07-01
UNKNOWN
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From DepressionNCT04448431 · 2020-06-18
COMPLETED
Vortioxetine in Patients With Depression and Early DementiaNCT04294654 · 2020-02-28
COMPLETED
Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in IndiaNCT04288895 · 2020-02-20
COMPLETED
Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)NCT04220996 · 2019-12-27
COMPLETED
Vortioxetine for Cancer Patients With Depression: An Observational StudyNCT04253678 · 2019-12-12
UNKNOWN
Tolerability, Safety and Efficacy of VortioxetineNCT04301492 · 2019-11-20
UNKNOWN
Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 DiabetesNCT03580967 · 2019-07-01
WITHDRAWN
Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)NCT03855865 · 2019-07-01
WITHDRAWN
Study With Vortioxetine on Emotional Functioning in Patients With DepressionNCT03835715 · 2019-02-05
COMPLETED
Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic AssessmentNCT03779789 · 2019-02-01
COMPLETED
Vortioxetine for Treatment of Depressive Mood and Alcohol UseNCT04498897 · 2019-01-25
UNKNOWN
Real-life Effectiveness of Vortioxetine in DepressionNCT03555136 · 2017-11-17
COMPLETED
Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of VortioxetineNCT02969876 · 2017-08-24
TERMINATED
THINC-it Vortioxetine - Sensitivity to ChangeNCT03053362 · 2017-05-24
COMPLETED
Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of AgeNCT03108625 · 2017-03-01
COMPLETED
Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive DisorderNCT02972632 · 2016-12-22
COMPLETED
The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive DisorderNCT02749721 · 2016-12-01
COMPLETED
Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI)NCT02845349 · 2016-10-01
WITHDRAWN
Cognitive Dysfunction in MDD PatientsNCT03187093 · 2016-10-01
UNKNOWN
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of AgeNCT02871297 · 2016-08-17
TERMINATED
Vortioxetine for MDD, Cognition, and Systemic Inflammatory BiomarkersNCT02637466 · 2016-07-01
WITHDRAWN
Vortioxetine vs Sertraline in MexicansNCT03978286 · 2016-06-30
COMPLETED
Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery DiseaseNCT02454426 · 2016-04-01
WITHDRAWN
Adjunctive Vortioxetine in SchizophreniaNCT02357797 · 2016-02-01
UNKNOWN
A Phase 3 Study of Lu AA21004 in Patients With Major Depressive DisorderNCT02389816 · 2015-04-10
COMPLETED
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)NCT02371980 · 2015-02-10
COMPLETED
Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking VortioxetineNCT02332954 · 2015-02-01
COMPLETED
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety DisorderNCT02294305 · 2014-12-01
UNKNOWN
Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionNCT01364649 · 2011-06-01
COMPLETED
Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderNCT01355081 · 2011-05-01
COMPLETED
Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderNCT01255787 · 2010-11-01
COMPLETED
Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension StudyNCT01152996 · 2010-09-01
COMPLETED
Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderNCT01179516 · 2010-08-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.